Ultralife Q2 revenue up 13% to $48.6M on Electrochem; margin down, GAAP EPS $0.05 vs $0.18

ULTRALIFE CORP

2025-Q2 EPS reported $0.17 revenue$99,307,000

Sales $48.6M (+13% YoY); organic Battery & Energy flat, Communications Systems down 57.2% to $2.7M.
Gross margin fell to 23.9% from 26.9% due to product mix, tariffs, and lower factory throughput.
Operating income $2.3M vs $3.9M; GAAP EPS $0.05 vs $0.18; adjusted EPS $0.07 vs $0.22.
Backlog with high-confidence orders $89M vs $95M at Q1 2025; debt prepaid $2.7M.
CEO expects improved results in H2 2025 on rebound in Communications and new product orders.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.